Related references
Note: Only part of the references are listed.Comparison of Agar Dilution to Broth Microdilution for Testing In Vitro Activity of Cefiderocol against Gram-Negative Bacilli
Mariana Albano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
High frequency of blaPER-1 gene in clinical strains of Acinetobacter baumannii and its association with quorum sensing and virulence factors
Fariba Naeimi Mazraeh et al.
GENE REPORTS (2021)
Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
Alejandro Iregui et al.
MICROBIAL DRUG RESISTANCE (2020)
Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region
Brian D. Johnston et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria
Shazad Mushtaq et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3
Saquib Malik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel et al.
DRUGS (2019)
ESBLs and resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa
Jose-Manuel Ortiz de la Rosa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
Takafumi Sato et al.
CLINICAL INFECTIOUS DISEASES (2019)
In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
Yoshinori Yamano
CLINICAL INFECTIOUS DISEASES (2019)
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Yohei Doi
CLINICAL INFECTIOUS DISEASES (2019)
Stability of cefiderocol against clinically significant broad-spectrum oxacillinases
Laurent Poirel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria
Akinobu Ito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016
Meredith A. Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
J. Dobias et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
Naoki Kohira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Tsukasa Ito-Horiyama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms
Roopali Sharma et al.
CLINICAL THERAPEUTICS (2016)
High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia
M. M. Aly et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology
Anais Potron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait
Leila Vali et al.
FRONTIERS IN MICROBIOLOGY (2015)
Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: Considerations on in vitro assay of active drugs
Maria Lina Mezzatesta et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Characterization of Acinetobacter baumannii Clinical Isolates Carrying blaOXA-23 Carbapenemase and 16S rRNA Methylase armA genes in Yemen
Sofiane Bakour et al.
MICROBIAL DRUG RESISTANCE (2014)
Clonal Diversity of Nosocomial Epidemic Acinetobacter baumannii Strains Isolated in Spain
Pilar Villalon et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Share Paper
